Literature DB >> 29523315

Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site.

Rohit Shukla1, Harish Shukla1, Timir Tripathi2.   

Abstract

Mycobacterium tuberculosis isocitrate lyase (MtbICL) is a crucial enzyme of the glyoxylate cycle and is a validated anti-tuberculosis drug target. Structurally distant, non-active site mutation (H46A) in MtbICL has been found to cause loss of enzyme activity. The aim of the present work was to explore the structural alterations induced by H46A mutation that caused the loss of enzyme activity. The structural and dynamic consequences of H46A mutation were studied using multiple computational methods such as docking, molecular dynamics simulation and residue interaction network analysis (RIN). Principal component analysis and cross correlation analysis revealed the difference in conformational flexibility and collective modes of motions between the wild-type and mutant enzyme, particularly in the active site region. RIN analysis revealed that the active site geometry was disturbed in the mutant enzyme. Thus, the dynamic perturbation of the active site led to enzyme transition from its active form to inactive form upon mutation. The computational analyses elucidated the mutant-specific conformational alterations, differential dominant motions, and anomalous residue level interactions that contributed to the abrogated function of mutant MtbICL. An understanding of interactions of mutant enzymes may help in modifying the existing drugs and designing improved drugs for successful control of tuberculosis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Active site; Collective motions; Molecular dynamic simulation; Mycobacterium tuberculosis; Principal component analysis; Residue interaction network

Mesh:

Substances:

Year:  2017        PMID: 29523315     DOI: 10.1016/j.tube.2017.11.013

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  5 in total

1.  Identification and characterization of glyceraldehyde 3-phosphate dehydrogenase from Fasciola gigantica.

Authors:  Purna B Chetri; Rohit Shukla; Timir Tripathi
Journal:  Parasitol Res       Date:  2019-01-31       Impact factor: 2.289

2.  Chemo-informatics guided study of natural inhibitors targeting rho GTPase: a lead for treatment of glaucoma.

Authors:  Sumit Kumar Rai; Rajesh Kumar Pathak; Dev Bukhsh Singh; Arun Bhatt; Mamta Baunthiyal
Journal:  In Silico Pharmacol       Date:  2021-01-03

3.  Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer.

Authors:  Divya Dhasmana; Ashutosh Singh; Rohit Shukla; Timir Tripathi; Neha Garg
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

4.  High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer's disease using computational approaches.

Authors:  Rohit Shukla; Tiratha Raj Singh
Journal:  J Genet Eng Biotechnol       Date:  2021-05-04

5.  Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.

Authors:  Collins U Ibeji; Nor Amirah Mohd Salleh; Jia Siang Sum; Angela Chiew Wen Ch'ng; Theam Soon Lim; Yee Siew Choong
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.